Technavio says global type 2 diabetes drugs market to surpass $53 billion by 2020
This market research study presents a detailed segmentation of the global type 2 diabetes drugs market by drug class (insulin, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors, and others) and by geography (Americas, APAC, and EMEA). The top vendors identified in the market are Novo Nordisk, Sanofi, Merck, Eli Lily, and AstraZeneca. Technavio’s market…